Effect of Mindfulness-Based Self-Compassion Program on Self-Compassion, Secondary Traumatic Stress, and Professional Quality of Life in Midwives and Nurses Working in Obstetrics: A Randomized Controlled Trial

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
AgeNot listed
SponsorAgri Ibrahim Cecen University

About this trial

This study aims to examine the effect of a Mindfulness-Based Self-Compassion Program on self-compassion levels, secondary traumatic stress, and professional quality of life in midwives and nurses working in obstetrics. Healthcare professionals in this field are frequently exposed to traumatic experiences such as complicated deliveries, perinatal loss, and obstetric emergencies, which may lead to secondary traumatic stress and reduced professional quality of life over time. This study is designed as a pre-test/post-test randomized controlled trial. A total of 80 participants (40 intervention, 40 control) will be recruited from Gaziantep Cengiz Gökçek Obstetrics and Pediatrics Hospital. The intervention group will receive an 8-week Mindfulness-Based Self-Compassion Program (one session per week, 60-90 minutes each). The control group will receive no intervention. Outcomes will be measured before and after the program using validated scales for self-compassion, secondary traumatic stress, and professional quality of life.

Eligibility criteria

Qualifiers

Working as a midwife or nurse in obstetrics

Actively employed in the relevant unit of the study institution

18 years of age or older

Able to read and understand Turkish

Disqualifiers

Incomplete or incorrect completion of data collection forms

Leaving the institution or withdrawing from the study during the research process

Failure to complete post-test measurements

Having participated in a self-compassion, mindfulness, or similar psychoeducation program within the last six months

Trial design

Treatments tested in this trial

  • Mindfulness-Based Self-Compassion Program

Treatment groups

80 Participants
are divided into 2 treatment groups

Locations

This trial has no locations

Sponsors and collaborators